Headlines

Evaluating Pacira BioSciences: Insights From 8 Financial Analysts

Latest Ratings for PCRX

Date Firm Action From To
Feb 2022 Wedbush Maintains Outperform
Feb 2022 HC Wainwright & Co. Maintains Buy
Jan 2022 Barclays Maintains Overweight

View More Analyst Ratings for PCRX

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *